[Micronutritional supplementation in the ARMD].

M. Pinazo-Durán,I. Vinuesa-Silva

Archivos de la Sociedad Española de Oftalmología

Abstract:

What problem does this paper attempt to address?

Soft Tissue Tumors Of The Lower Leg, Foot And Ankle: A Cross-Sectional Observational Study Analysing 376 Cases

Joanne M Jenkins,Sanjay Gupta,Ashish Mahendra,Christopher Del Balso,Sam Park,Timothy Daniels,Mansur Halai

DOI: https://doi.org/10.1053/j.jfas.2024.09.005

IF: 1.345

2024-10-05

The Journal of Foot & Ankle Surgery

Abstract:Fewer than 5% of soft tissue sarcomas arise in the foot and ankle. It can be difficult to distinguish between benign and malignant lesions which leads to a delay in diagnosis. Initial inappropriate procedures limit options for limb salvage and increasing rates of local recurrence. Our aim is to improve understanding of the presentation and management of these rare tumors to reduce delays in diagnosis and decrease the occurrence of inappropriate or unwarranted procedure. A prospectively maintained database of 376 new referrals to the West of Scotland regional musculoskeletal oncology service for soft tissue lesions of the foot, ankle, and lower leg over a 10-year period was analysed retrospectively. An assessment was made of patient demographics, presentation, anatomical location, diagnosis, classification, management, and outcomes for all patients. Of all new referrals, 53.5% were diagnosed with primary benign soft tissue tumors and 16% with primary malignant soft tissue tumors. The most common primary benign tumor in our population was schwannoma (15.9%) and primary malignant tumor was undifferentiated sarcoma (26.7%). In the foot alone, soft tissue sarcomas most commonly occurred in the forefoot (44.4%). The most common presenting complaints were rest pain and focal swelling. Symptoms were present for on average 7 months prior to referral. Death from disease in sarcomas was 41.7% over a 10 year follow up period, higher than other body areas. Soft tissue sarcomas in the foot and ankle remain a diagnostic challenge. Local biopsies should only be performed following discussion with an oncology surgeon. We have provided a management protocol in order to reduce the number of inappropriate procedures performed in this group and expedite referral to specialist centres, optimising clinical outcomes and reducing the cost of litigation to healthcare services.

surgery,orthopedics
Symptoms and Signs Associated with Benign and Malignant Proximal Fibular Tumors: a Clinicopathological Analysis of 52 Cases.

Tao Sun,Lingxiang Wang,Changzhi Guo,Guochuan Zhang,Wenhai Hu

DOI: https://doi.org/10.1186/s12957-017-1162-z

2017-01-01

World Journal of Surgical Oncology

Abstract:BACKGROUND:Malignant tumors in the proximal fibula are rare but life-threatening; however, biopsy is not routine due to the high risk of peroneal nerve injury. Our aim was to determine preoperative clinical indicators of malignancy.METHODS:Between 2004 and 2016, 52 consecutive patients with proximal fibular tumors were retrospectively reviewed. Details of the clinicopathological characteristics including age, gender, location of tumors, the presenting symptoms, the duration of symptoms, and pathological diagnosis were collected. Descriptive statistics were calculated, and univariate and multivariate regression were performed.RESULTS:Of these 52 patients, 84.6% had benign tumors and 15.4% malignant tumors. The most common benign tumors were osteochondromas (46.2%), followed by enchondromas (13.5%) and giant cell tumors (13.5%). The most common malignancy was osteosarcomas (11.5%). The most common presenting symptoms were a palpable mass (52.0%) and pain (46.2%). Pain was the most sensitive (100%) and fourth specific (64%); both high skin temperature and peroneal nerve compression had the highest specificity (98%) and third sensitivity (64%); change in symptoms had the second highest specificity (89%) while 50% sensitivity. Using multivariate regression, palpable pain, high skin temperature, and peroneal nerve compression symptoms were predictors of malignancy.CONCLUSIONS:Most tumors in the proximal fibula are benign, and the malignancy is rare. Palpable pain, peroneal nerve compression symptoms, and high skin temperature were specific in predicting malignancy.
Tumours of the foot: A 10 years retrospective analysis

Vivek Ajit Singh,Vinesh Sandhu,Choo Tze Yong,Nor Faissal Yasin

DOI: https://doi.org/10.1177/10225536241248706

2024-04-27

Journal of Orthopaedic Surgery

Abstract:Journal of Orthopaedic Surgery, Volume 32, Issue 1, January-April 2024. IntroductionThe foot is a complex structure composed of several tissues, each of which can be the origin of the proliferation and development of the tumour. Most lesions about the foot are reactive or inflammatory, but some are true neoplasms.MethodThis is a retrospective analysis of 4997 patient records treated in the Orthopaedic Oncology Unit of University Malaya Medical Centre, Malaysia, between 1 January 2010 to 31 December 2020. Demographic data of 195 patients with foot tumours were analysed out of 4997 neoplasm patients.ResultsThere were 195 cases of foot tumours: 148 were benign, and 47 were malignant. 47 were bone tumours, 4 were metastases, and 144 were soft tissue tumours. Six patients succumbed to the disease, two cases of giant cell tumour (GCT) and one patient with synovial sarcoma had a recurrence. Treatment of foot tumours was wide resection in general. However, in metastasis cases, amputation was done. The majority of tumours were in the toes and dorsum of the foot. Soft tissue tumours of the foot occur in the elderly population in contrast to bone tumours, mainly in the second decade of life. The gender distribution was almost equal for foot tumours. Ganglion and Giant Cell Tumour of the bone are the commonest benign soft tissue and bone tumours. The most common malignant soft tissue and bone tumours are malignant melanoma and chondrosarcoma. The amputation rate is 5.64% the recurrence rate is 1.54%. Mortality rate is 3.08%. The MSTS score is 79%, and the TESS score is 76.23%.ConclusionFoot tumours are relatively rare, mostly originating from soft tissue and exhibiting a benign nature. Nonetheless, a noteworthy proportion—approximately a quarter of these tumours—demonstrate malignancy. The surgical interventions undertaken in managing these tumours and associated functional outcomes generally yield acceptable results.

surgery,orthopedics
Operative and Nonoperative Risks in the Cardiac Patient †

J. Sapala,J. L. Ponka,W. Duvernoy

DOI: https://doi.org/10.1111/j.1532-5415.1975.tb00627.x

1975-12-01

Journal of the American Geriatrics Society

Abstract:Four hundred and sixteen patients with documented arteriosclerotic heart disease (ASHD) underwent 424 diagnostic and therapeutic surgical procedures during the year 1970 at the Henry Ford Hospital. They were classified according to the specific clinical manifestation of their cardiac abnormality. Patients with a history of old, well‐compensated myocardial infarction, and those with cardiac arrhythmia, bundle‐branch block, congestive heart failure and A‐V block (pacemaker‐protected) but no evidence of previous myocardial infarction fared almost as well as subjects of the same age without cardiac disease, and were considered to run the lowest operative risk. Patients with angina, especially if there was a history of infarction, were an intermediate risk in terms of complications and mortality. Patients with a history of previous infarction complicated at the time of the surgical procedure by arrhythmia, A‐V block, bundle‐branch block, or congestive heart failure were in the “highest risk” category. A severe A‐V block indicated the need for insertion of a “prophylactic” pacemaker before any attempt at a diagnostic or therapeutic procedure. No patient with clinical or electrocardiographic evidence of a recent infarction (less than three months' duration) should undergo any elective surgical procedure under any form of anesthesia unless the surgeon is prepared for a high mortality rate that may approach 90 percent. In contrast, the patient with old, well‐compensated myocardial infarction and no evidence of dysrhythmia, block or congestive failure can tolerate even a major surgical operation under any form of anesthesia extremely well.
Benefits Associated With Early Diagnosis and Treatment of Soft Tissue Sarcomas of the Foot and Ankle

Drew Murray,Jacob Topfer,Alexander P Decilveo,James C Wittig

DOI: https://doi.org/10.1053/j.jfas.2016.05.001

Abstract:Soft tissue sarcomas arising in the foot and ankle are often misdiagnosed, resulting in excision without adequate preoperative staging or surgical margins. The goal of the present study was to review a case series of soft tissue sarcomas of the foot and ankle with attention directed at unplanned excisions of sarcomas. An unplanned excision means that a patient either underwent an inadequate preoperative workup or the preoperative workup indicated a benign entity, resulting in surgical resection. We retrospectively analyzed the medical records of 10 patients with sarcomas of the foot and ankle treated at our institution. All soft tissue sarcomas were excised with the widest margin possible without any major bone or neurovascular resection to allow for preservation of the foot. All patients were followed up for a minimum of 8 months to assess pain, function, and complications. The patients were followed up for an average of 22.4 (range 8 to 44) months. Of the 10 patients, 6 had undergone preoperative magnetic resonance imaging without contrast and the sarcomas were read as benign or cystic masses. Two patients had undergone preoperative magnetic resonance imaging with contrast, and these scans were also misread. Despite having undergone previous unplanned surgery, none of these sarcomas had recurred after repeat resection with a wider margin at a mean follow-up of 22.4 (range 8 to 44) months. At the last follow-up point, 8 patients were alive without evidence of disease. Minor complications included lymph edema in 1, stress fracture in 1, and wound infection in 1 that resolved. Preoperative MRI with contrast is recommended before resecting any soft tissue masses of the foot and ankle. In the event of an unplanned excision of a soft tissue sarcoma, the patient should be referred to an orthopedic oncologist for definitive surgery to optimize the oncologic and functional results. In the present retrospective analysis, previous intervention did not seem to affect the prognosis, including local recurrence, distant metastasis, disease-free interval, and functional outcomes.
Update on the Perspective of a University Tumour Institute

Christian Scheele,Andreas Toepfer,Simone Beischl,Dietmar Dammerer,Norbert Harrasser,Rüdiger von Eisenhart-Rothe,Florian Lenze

DOI: https://doi.org/10.3390/jcm13020350

IF: 3.9

2024-01-09

Journal of Clinical Medicine

Abstract:The rarity of foot and ankle tumours, together with the numerous histological entities, presents a challenge in accumulating sufficient patients to draw reliable conclusions. Therefore, we decided to present an update of a retrospective analysis of their distribution patterns, comprising 536 cases of foot and ankle tumours presented to our tumour board between June 1997 and June 2023. Our aim was to provide a comprehensive overview of the prevalence and distribution patterns of benign and malignant bone and soft tissue tumours of the foot and ankle. A total of 277 tumours involved bone (51.7%). Of these, 242 (87.4%) were benign and 35 (12.6%) were malignant. In addition, 259 soft tissue tumours (48.3%) were found, of which 191 (73.7%) were benign and 68 (26.3%) were malignant. The most common benign bone tumours were simple bone cysts, enchondromas, osteochondromas, aneurysmal bone cysts, and lipomas of bone. Common benign soft tissue tumours included a tenosynovial giant cell tumour, haemangioma, plantar fibromatosis, schwannoma, and lipoma. The most common malignant soft tissue tumours were synovial sarcoma, malignant melanoma, and myxofibrosarcoma. In terms of anatomical location, the hindfoot was the most common site (28.7%), followed by the midfoot (25.9%), ankle (25.4%), and forefoot (20.0%). The distribution of benign entities often follows typical patterns, which may facilitate an early diagnosis even without biopsy (e.g., simple bone cyst, plantar fibromatosis). On the other hand, the distribution patterns of many rare or malignant entities are inconsistent. Individual soft tissue malignancies occur very sporadically, even over long periods of time and in specialized tumour centres. It is therefore important to recognise that any suspicious mass in the foot and ankle must be considered a possible malignancy until proven otherwise.

medicine, general & internal
Enhanced accuracy and reduced delay in diagnosing bone tumors within an expert sarcoma network: A nationwide study

Vincent Crenn,François Lataste,Louise Galmiche,Louis-Romée Le Nail,Mickaël Ropars,Jean-Yves Blay,Gonzague de Pinieux,Francois Gouin

DOI: https://doi.org/10.1016/j.ejso.2024.108271

IF: 4.037

2024-03-21

European Journal of Surgical Oncology

Abstract:Introduction Primary bone tumors encompass a range of rare and diverse lesions. Pathological diagnosis poses significant challenges, with histological discrepancies extensively studied in soft tissue sarcomas but lacking specific investigation in bone lesions. This study aimed to determine the rate of major diagnostic discrepancies in primary bone tumors, assessing whether initial histological analysis within an expert referral center network reduces this rate and final diagnostic delay. Additionally, we examined the impact of mandatory systematic re-reading by expert pathologists on diagnostic variation and readjustment. Methods Our study cohort comprised patients with primary bone tumors, drawn from the national prospective French sarcoma network database. A total of 1075 patients were included from 2018 to 2019. Results The cohort exhibited a major discrepancy rate of 24%. Within the expert referral centers network, 49 cases (7%) showed major diagnostic discrepancies in the initial analysis, compared to 207 cases (57%) outside the network (p < 0.001). Regarding the final diagnostic delay, a mean of 2.8 weeks (±4.9) was observed within the network, contrasting with 6.5 weeks (±9.1) outside the network (p < 0.001). Systematic re-reading by an expert pathologist facilitated diagnosis readjustment in 75% of the 256 cases, with 68% of all diagnostic variations occurring preoperatively. Conclusion Early management within the expert network significantly reduced major diagnostic discrepancies and shortened the diagnosis delay by approximately a month. Expert pathologist systematic re-readings were responsible for diagnosis readjustments in three-quarters of cases, with two-thirds of all diagnostic variations occurring preoperatively, thereby mitigating the consequences of mistreatment.

oncology,surgery
Malignant Fibrous Neoplasms of Long Bones: Analysis of the Surveillance, Epidemiology, and End Results Database from 1973 to 2015

Yiting Huang,Jianqiao Hong,Jiahong Meng,Haobo Wu,Mingmin Shi,Shigui Yan,Wei Wang

DOI: https://doi.org/10.1186/s12891-019-2971-8

IF: 2.562

2020-01-01

BMC Musculoskeletal Disorders

Abstract:Abstract Background Malignant fibrous neoplasms (MFN) of long bones are rare lesions. Moreover, the prognostic determinants of MFN of long bones have not been reported. This study aimed to present epidemiological data and analyse the prognostic factors for survival in patients with MFN. Materials and methods The Surveillance, Epidemiology, and End Results (SEER) programme database was used to screen patients with malignant fibrous neoplasms (MFN) of long bones from 1973 to 2015, with attention to fibrosarcoma, fibromyxosarcoma, periosteal fibrosarcoma and malignant fibrous histiocytoma. The prognostic values of overall survival (OS) and cancer-specific survival (CSS) were assessed using the Cox proportional hazards regression model with univariate and multivariate analyses. The Kaplan–Meier method was used to obtain OS and CSS curves. Results A total of 237 cases were selected from the SEER database. Malignant fibrous histiocytoma was the most common form of lesion in long bones. Multivariate analysis revealed that independent predictors of OS included age, stage, tumour size and surgery. Age, stage, tumour size and surgery were also independent predictors of CSS. Additionally, the most significant prognostic factor was whether metastasis had occurred at the time of initial diagnosis. Conclusion Among patients with MFN of long bones, age (> 60 years), tumour size (> 10 cm), distant stage, and non-surgical treatment are factors for poor survival.
Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas

J. Sharma,S.V.S. Deo,S. Kumar,A.W. Barwad,S. Rastogi,D.N. Sharma,G. Singh,S. Bhoriwal,A. Mishra,R. K,J. Saikia,A. Mandal,B. Bansal,M. Gaur

DOI: https://doi.org/10.1016/j.clon.2024.01.018

IF: 4.925

2024-02-01

Clinical Oncology

Abstract:AIMS: Synovial sarcoma is a rare but aggressive variant of soft-tissue sarcoma. Literature is sparse and reported mostly from the West. We analysed the clinical profiles and prognostic factors of extremity synovial sarcoma patients in order to study their clinical journey.MATERIALS AND METHODS: This was a retrospective analysis. All patients with extremity synovial sarcoma treated between 1992 and 2020 were included. Patients with metastases at presentation were excluded. A descriptive analysis of demographic and clinicopathological features of patients undergoing limb salvage surgery (LSS) or amputation was carried out. Overall survival and disease-free survival were calculated for the entire cohort as well as for the LSS and amputation groups. Factors prognostic for survival were identified.RESULTS: In total, 157 patients had localised extremity synovial sarcoma. Predominantly, young adults (median 31 years) and males (61%) were affected. Over 70% of patients presented after recurrence or unplanned surgeries. Sixty-seven per cent of tumours were >5 cm, 69% were deep and 23% involved bone. The limb salvage rate was 64%. In the LSS group, adjuvant radiotherapy and chemotherapy were given to 72% and 68% of patients, respectively. In the amputation group, 72% of patients received adjuvant chemotherapy. In a median follow-up of 59 months, 39.4% of patients had recurrences, the majority (61.2%) were systemic. Five-year overall survival and disease-free survival were 53.4% and 49.8%, respectively. Overall survival was 63.9% and 29.7% in the LSS and amputation groups, respectively. On multivariate analysis, tumour size, depth, omission of radiotherapy and bone invasion were found to be the adverse prognostic factors.CONCLUSION: This is one of the largest studies on extremity synovial sarcoma. Mostly males and young adults were affected. The limb salvage rate was 64%, despite most being referred after unplanned surgery. Almost 70% of patients received radiotherapy and chemotherapy. Overall survival was inferior in the amputation group. Tumour size >5 cm, depth and bone invasion were negative, whereas adjuvant radiotherapy was a positive prognostic factor for survival. Chemotherapy had no impact on survival.

oncology
Clinical features and surgical management of metastatic skeletal diseases distal to the elbow and knee

Lin HUANG,Wei GUO,Rong-li YANG,Xiao-dong TANG,Tai-qiang YAN

DOI: https://doi.org/10.3969/j.issn.2095-252X.2014.07.003

2014-01-01

Abstract:Objective The morbidity of metastatic lesions distal to the elbow and knee is quite low. To analyze the clinical characteristics and prognostic factors of metastatic diseases distal to the elbow and knee and to investigate the therapeutic strategies for such lesions.Methods A total of 30 patients ( 41 lesions ) with metastatic lesions in the distal extremities were treated from January 2000 to June 2013. The hospital records, radiographic reports and pathological results of each patient were reviewed, so as to summarize the clinical features and diagnostic points. 41 lesions included the tibia (n=21 ), the ulnar (n=8 ), the ifbula (n=6 ), the radius (n=3 ) and the foot (n=3 ). The Visual Analogue Scale ( VAS ) scoring system was used to evaluate the pain in the patients. Pathological fractures were detected in 4 patients, and the risk of impending pathological fractures in the other patients was evaluated by the Mirels scoring system. The surgical treatment was performed on 28 patients, whose postoperative functions were evaluated by the Musculoskeletal Tumor Society ( MSTS ) scoring system. The survival rate was described with the Kaplan-Meier survival curve, and the prognostic factors were analyzed by t-test.Results The median postoperative survival time and the mean postoperative survival time were 9 months and 13 months respectively. The half-year, 1-year and 2-year survival rates were 80.8%, 24.4% and 12.2%. The average Mirels score was 9.56 points in the patients with long bone metastases but without pathological fractures. The mean VAS score of the patients was 6.86 points at admission, which turned out to be 2.63 points after the operation. The mean postoperative MSTS score was 22.85 points.Conclusions The morbidity of metastatic diseases distal to the knee and elbow is very low. Detailed history-taking, appropriate radiographic examinations and oncology tests are essential for accurate diagnosis and avoidance of misdiagnosis. Biopsy is required when a deifnite diagnosis cannot be made. The quality of life of the patients can be signiifcantly improved with the surgical treatment combined with the postoperative radiotherapy and systemic therapy.
[Experimental phaco-emulsification in the rabbit. Induced corneal endothelial lesions, regeneration at 24 hours (author's transl)].

J. M. Chansel,R. Vidal,H. Hamard

Abstract:The purpose of this study was to evaluate action of the Shock phacofragmentor's tip vibrations; this study was done in rabbit corneal endothelium: 1--Tip in the anterior chamber close to the cornea and iterative entrances by the incision; 2--In order to avoid some endothelial injuries, it appears necessary to introduce the instrument only once and also use the vibrations only inside the nucleus. Then the lens materials can be removed by irrigation and or aspiration.
Osteosarcomas of the hand and foot: A sarcoma‐center case series experience

Michal Mahdal,Vasileios Apostolopoulos,Lukáš Pazourek,Iva Zambo,Dagmar Adámková,Peter Múdry,Dušan Zoufalý,Tomáš Tomáš

DOI: https://doi.org/10.3892/ol.2024.14800

2024-11-13

Oncology Letters

Abstract:Hand and foot osteosarcoma represents ~1% of all diagnosed cases of osteosarcoma. The rarity of osteosarcoma of the hand and foot leads to frequent misdiagnosis, delayed diagnosis or incorrect treatments, which can lead to fatal consequences. Typically, salvaging the affected limb is the treatment of choice, and with the use of chemotherapy, 60‐65% of patients with osteosarcoma can be treated without amputation. Due to its rarity, misdiagnosis and treatment delays are common, yet detailed reviews and analyses of such cases are limited. The present retrospective cohort study aimed to review and analyze cases of osteosarcoma located in the hand and foot. From January 2007 to January 2019, 11 patients were treated at the Masaryk Memorial Cancer Institute Sarcoma Center (Brno, Czechia), 5 cases affected the hand and 6 affected the foot. A total of 6 male patients and 5 female patients, with a mean age of 30.9±16.74 years, were diagnosed with hand or foot osteosarcoma. The mean follow‐up period was 90.36±66.14 months. The mean tumor size detected during diagnosis was 4.29±1.81 cm. Osteoblastic osteosarcoma was the most common histopathological type, accounting for 4 cases (33.4%). A majority of the osteosarcomas were identified as high grade (81.8%). A total of 5 patients experienced misdiagnoses following their initial biopsy, with 2 patients initially receiving treatment outside the Masaryk Memorial Cancer Institute Sarcoma Center. The most frequently encountered misdiagnosis was giant‐cell tumor of the bone. A total of 3 patients underwent limb amputation and 2 patients developed lung metastasis and succumbed to the disease. The disease‐free survival period and overall survival rate were calculated using Kaplan‐Meier survival analysis. The mean disease‐free survival period was 82.83±60.05 months, while the overall survival rate was 72%, with a mean survival time of 90.36±56.73 months. In summary, an examination of a case series involving 11 patients diagnosed with osteosarcoma of the hand and foot was conducted. The treatment approach, clinical characteristics and patient outcomes were described. A total of four case studies of patients with osteosarcoma in the hand or foot were presented. Misdiagnosis of this disease may result in the inappropriate treatment being administered to patients, therefore, the correct and rapid diagnosis of disease is necessary for effective treatment of hand and foot osteosarcomas.

oncology
Lateral malleolus en bloc resection for the distal fibula osteosarcoma based on a new classification and proposed reconstruction choice: analysis of 6 cases prognosis and literature review

Jun Wang,Zhiye Du,Rongli Yang,Xiaodong Tang,Wei Guo

DOI: https://doi.org/10.1016/j.fas.2019.11.003

IF: 2.84

2020-01-01

Foot and Ankle Surgery

Abstract:Background: Amputation has been regarded as the standard surgical treatment for distal fibula osteosarcoma. With the advances in surgery and adjuvant chemotherapy, it have made limb salvage possible. However, the choice of a specific reconstruction procedure is frequently based on the surgeon's preference and it lacks of guidelines and high quality studies with the objective result on the subject. Materials and methods: Six patients with the distal fibular osteosarcoma which were received biological reconstruction were retrospectively reviewed at our bone tumor center from November 2003 to November 2015. There were 6 male with a mean age of 24.2 years (range, 12-47 years). The minimum follow-up duration was 53.3 months (median, 96.3 months; average, 108.4 months; range, 53.3-204.1 months). No patient was lost at the last follow-up. All data were obtained from the clinical and radiograph records. Furthermore, the literature review was based on the Google Scholar, Medline, EMBASE and Pubmed databases. The search was performed using the terms "distal fibula", "lower limb tumour", "sarcoma", "fibular metastasis" and "limb-salvage surgery" for the literature review from 1979 to 2017. Results: Of the six patients with the final follow-up in the present study, four cases (83.3%, 4/6) achieved excellent prognosis without oncologic complications. A second surgical procedure was performed in two patients, one to treat local recurrence and one to receive metastasectomy due to the pulmonary metastasis. Case 6 received the below knee amputation due to recurrence. All the cases available for functional evaluation at the final follow-up had a mean functional MSTS score of 29.6 (range, 28-30) except case 6 receiving the amputation below the knee. Meanwhile, the VAS evaluation had a mean functional score of 0.2 points (range, 0-1 points). The results of our cohort and literature review illustrated that the patient with the malignant tumor of lateral malleolus could obtain excellent oncological prognosis and ankle function. Conclusions: We have provided treatment recommendations depending on the tumor volume and associated extent and proposed the primary ankle arthrodesis was performed after en bloc resection of Type II and III lateral malleolus osteosarcoma, based on the proposed classification. Furthermore, the patient with the malignant tumor of lateral malleolus could obtain excellent oncological prognosis. (C) 2019 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.
The clinical significance of indeterminate pulmonary nodules in patients with primary bone sarcoma: a systematic review

M Shihabul Hassan,Sisith Ariyaratne,Christine Azzopardi,Karthikeyan P Iyengar,Arthur Mark Davies,Rajesh Botchu

DOI: https://doi.org/10.1093/bjr/tqae040

2024-02-12

British Journal of Radiology

Abstract:Abstract Objective To report the incidence of indeterminate pulmonary nodules (IPN) and the rate of progression of IPNs to metastasis in patients with primary bone cancers. We also aimed to evaluate clinical or radiological parameters that may identify IPNs more likely to progress to metastatic disease and their effect on overall or event-free survival in patients with primary bone sarcoma. Methods A systematic search of the electronic databases Medline, Embase, and Cochrane Library was undertaken for eligible articles on IPNs in patients with primary bone sarcomas, published in the English language from inception of the databases to 2023. The Newcastle-Ottawa Quality Assessment Form for Cohort Studies was utilized to evaluate risk of bias in included studies. Results Six studies, involving 1667 patients, were included in this systematic review. Pooled quantitative analysis found the rate of incidence of IPN to be 18.1% (302 out of 1667) and the rate of progression to metastasis to be 45.0% (136 out of 302). Nodule size (more than 5 mm diameter), number (more than or equal to 4), distribution (bilaterally distributed), incomplete calcification, and lobulated margins were associated with an increased likelihood of IPNs progressing to metastasis, however, their impact on overall or event-free survival remains unclear. Conclusion The risk of IPNs progressing to metastasis in patients with primary bone sarcoma is non-negligible. Large IPNs have a high risk to be an actual metastasis. We suggest that IPNs in these patients be followed up for a minimum of 2 years with CT imaging at 3, 6, and 12 month intervals, particularly for nodules measuring >5 mm in average diameter. Advances in knowledge This is the first systematic review on IPNs in patients with primary bone sarcomas only and proposes viable management strategies for such patients.

radiology, nuclear medicine & medical imaging
P059 Cutaneous sarcomas: a 5-year review of treatment outcomes and literature

Jenny Chung,Chrystalla Macedo,Rishika Sinha

DOI: https://doi.org/10.1093/bjd/ljae090.086

IF: 11.113

2024-06-28

British Journal of Dermatology

Abstract:Abstract Cutaneous sarcomas comprise 5% of skin cancers yet carry great morbidity and mortality. They include atypical fibroxanthoma (AFX), pleomorphic dermal sarcoma (PDS), leiomyosarcoma (LMS), dermatofibrosarcoma protuberans (DFSP) and angiosarcoma (AS) (Stoneham S, Hunter A, Raahimi M et al. Cutaneous sarcoma: a review and practical approach to management. Clin Exp Dermatol 2023; 48: 866–72). Standardized agreed national guidelines for the management of these rare tumours are lacking, and we rely on guidance from sarcoma specialists (Dangoor A, Seddon B, Gerrand C et al. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res 2016; 6: 20). However, these tumours are lower grade, and do not carry the same local and metastatic recurrence risk as noncutaneous sarcomas. The aim of this study at a tertiary UK centre was to review the treatment and follow-up outcomes of patients with sarcoma managed locally. All patients with biopsy-proven cutaneous sarcomas discussed at our skin cancer multidisciplinary team (MDT) from March 2020 to January 2024 were retrospectively reviewed. Patient demographics, and histology were gathered along with the treatments offered, recurrence and follow-up outcome. All patients were restaged using the American Joint Committee on Cancer soft tissue sarcoma criteria. In total 40 patients met the criteria; their mean age at diagnosis was 70 years (range 24–91) and 25% were immunosuppressed. The cohort was followed up for an average of 11.3 weeks (range 1–36). The diagnoses included PDS (35%), AFX (20%), LMS (20%), DFSP (15%) and AS (5%); all but one had T1 or T2 disease. Overall, 97% of patients received surgery first line, with a clearance rate of 85% (29 of 34). Two patients had recurrence: one with PDS, requiring further surgery, and one with AS, who was managed at a sarcoma unit. There were no metastases reported or deaths due to disease. Most patients (80%) remain in clinical remission. Appropriate imaging and follow-up recommendations were made in most cases, according to their diagnosis. In summary, many of the patients with cutaneous sarcoma in the study had superficial disease. Despite our conservative surgical margins offered and a short duration of follow-up, we observed a 5% recurrence rate with no metastases. This study highlights the importance of an MDT approach to cutaneous sarcomas, which helps draw expertise from different specialties. Our lower recurrence rate and metastases compared with literature suggests that patients with cutaneous sarcoma could be safely managed in local skin cancer MDTs. We propose national guidance to help similar skin cancer MDTs and clinicians to standardize and reduce variation in care, as well as to provide an evidence base on which to recommend monitoring of this rare group of tumours.

dermatology
Osteolytic lesions of the calcaneus: results from a multicentre study

Christian Weger,Andreas Frings,Jörg Friesenbichler,Robert Grimer,Dimosthenis Andreou,Felix Machacek,Karin Pfeiffenberger,Bernadette Liegl-Atzwanger,Per-Ulf Tunn,Andreas Leithner

DOI: https://doi.org/10.1007/s00264-013-2042-y

IF: 3.479

2013-08-22

International Orthopaedics

Abstract:PurposeTumours of the calcaneus are exceedingly rare and the correct diagnosis is often missed. X-rays are the standard clinical examination tool and therefore we wanted to discover whether X-rays alone were a sufficient diagnostic tool for these tumours. Diard’s classification was applied to define whether different types of lesions were characteristically distributed in the bone and in addition we analysed whether type and/or duration of symptoms were possible indicators of malignancy.MethodsNinety-two patients’ files (59 men and 33 women) were retrospectively reviewed. Seventy-five patients with a mean age at surgery of 28 years (range five to 78) were surgically treated. Parameters analysed were sex, age at surgery, side, type and duration of symptoms, tentative diagnosis, biopsy prior to surgery, operative procedure, recurrence rate, revision and localisation of the lesion according to Diard. For each lesion the first documented radiological diagnosis and—in cases of malignancy—Enneking’s classification was applied.ResultsDiscrepancies between the radiological and definitive histological diagnosis occurred in 38 (41 %) of 92 cases. In eight (osteosarcoma n = 5, Ewing’s sarcoma n = 2, metastases n = 1) of 17 malignant cases radiological examination initially gave no evidence of malignancy, resulting in an unplanned excision (“whoops procedure”) in three cases of osteosarcoma. Applying Diard’s system trabecular area 6 (radiolucent area) was highly affected in 64 (80 %) of 80 investigated plain X-rays, whereas areas 1 and 5 were affected in nine (11 %) and 16 (20 %) cases only.ConclusionsIn each case of an osteolytic lesion of the calcaneus a malignant tumour must be ruled out, and thus preoperative plain X-rays in two planes alone are not sufficient and should therefore be followed by magnetic resonance imaging. Applying the Diard system different types of lesions are not characteristically distributed in the bone. Increasing pain for more than ten days without previous trauma should always justify further examinations.

orthopedics
Surgical Treatment of Proximal Fibula Osteosarcoma: a Report of 18 Cases

Fan Gentao,Zhu Yan,Zhang Junliang,Cao Lili,Shi Xin,Wu Sujia,Zhou Guangxin

DOI: https://doi.org/10.3760/cma.j.issn.2095-7041.2019.03.002

2019-01-01

Abstract:Objective To explore surgical modalities, postoperative complications and management strategies of proximal fibula osteosarcoma ( PFOS). Methods Eighteen patients of PFOS admitted in our center between January 2007 to January 2016 were retrospective analyzed, including 11 male patients and 7 female patients with a median age of 17 ( range 8 -38) years. All the 18 patients reported pain as the chief complaint, including 8 patients with accompanying symptoms of common peroneal nerve paralysis,and 3 patients with masses. The median duration of disease was 1-24 weeks. According to Enneking surgical classification,there were 17 cases in stage ⅡB and one case in stage Ⅲ. Fifteen patients underwent neoadjuvant chemotherapy for proximal humeral osteosarcoma resection, including 13 cases of Malawer typeⅠ resection and 2 cases of type Ⅱ resection. There were 2 patients with incomplete resection in other hospitals who were amputation after admission. One patient ( stage Ⅲ) had lung metastasis at the time of admission. After two courses of chemotherapy, the primary tumor continued to grow, and the pain was not relieved. Amputation was performed. The knee joint function of 15 patients with limb salvage was evaluated using the Musculo Skeletal Tumor Society(MSTS) scoring system in 3 months after operation. Results All the 18 PFOS patients were followed up successfully for a mean of 59 (range 7-120) months, during which lung metastasis occurred in 8 patients, and death occurred in 5 patients( including 3 cases of amputation). Of the 15 patients with limb salvage, recurrence occurred in 4 patients; postoperative wound infection occurred in one patient which was cured after positive and intensified dressing change. Common peroneal nerve injury occurred in 5 patients, and two of them recovered spontaneously in 3 and 7 months after operation. One patient had mild lameness and two patients had perforation of the perforation. No knee joint instability occurred in all these 15 patients. MSTS function scores in 3 months after operation were good in 11 cases, moderate in 2 cases, and poor in 2 cases. Conclusions Correct selection of the initial surgical modality for the treatment of PFOS is critical. Surgical procedures are determined according to the extent of tumor invasion,and postoperative complications of proximal fibular osteosarcoma are acceptable. Knee joint stability can be achieved by simple in situ suturing of the knee joint lateral collateral ligament and the lateral head of the biceps femoris muscle.
Synovial Sarcoma in the Plantar Region: A Case Report and Literature Review

Jie Gao,Yifang Yuan,Ting Liu,Hao-Run Lv,Hailin Xu

DOI: https://doi.org/10.12998/wjcc.v7.i17.2549

2019-01-01

World Journal of Clinical Cases

Abstract:Synovial sarcoma (SS), a rare malignant soft tissue tumor whose histological origin is still unknown, often occurs in limbs in young people and is easily misdiagnosed.We report a 24-year-old man who sought treatment for plantar pain thought to be caused by a foot injury that occurred 4 years prior. Currently, he had been seen at another hospital for a 1-wk history of unexplained pain in the left plantar region and was treated with acupuncture, a kind of therapy of Chinese medicine, which partly relieved the pain. Because of this, the final diagnosis of biphasic SS was made after two subsequent treatments by pathological evaluation after the last operation. SS is rarely seen in the plantar area, and his history of a left plantar injury confused the original diagnosis.This study shows that pathological and imaging examinations may play a vital role in the early diagnosis and treatment of SS.
Contemporary surgical management of osteosarcoma and Ewing sarcoma

Alexandra K. Callan,John H. Alexander,Nicole I. Montgomery,Antoinette W. Lindberg,Thomas J. Scharschmidt,Odion Binitie

DOI: https://doi.org/10.1002/pbc.31374

2024-10-17

Pediatric Blood & Cancer

Abstract:The incidence of malignant bone tumors has remained relatively stable over the past two decades between 8% and 9% per 1,000,000 in North America. Multidisciplinary treatment is paramount for optimal care combining surgical resection, chemotherapy, and rehabilitation. Surgical treatment aims for a negative margin resection of the sarcoma with a personalized reconstruction plan. Limb salvage surgery (LSS) is possible in the majority of cases; however, amputation (including rotationplasty) may be required or preferred. Reconstruction can be achieved utilizing endoprostheses, allograft, autograft, or a combination of these techniques. Emerging technologies such as 3D printing of implants and cutting guides, and intraoperative navigation have helped to improve options for LSS.

oncology,pediatrics,hematology
[The Survival and Functional Outcome of Primary Bone Sarcomas in Distal Lower Extremity].

Tai-qiang Yan,Wei Guo,Rong-li Yang,Xin Sun,Hua-yi Qu

DOI: https://doi.org/10.3760/cma.j.issn.0529-5815.2010.20.009

2010-01-01

Abstract:OBJECTIVE:To analyze the oncological and functional outcome of limb salvage in this location.METHODS:From November 2003 to January 2010, 20 patients with primary malignant bone tumors of the distal lower extremity were treated. There were 15 male and 5 female, the mean age was 20 years. Among 14 patients with malignant distal tibial sarcoma, 11 patients had ankle arthrodesis reconstructed by using allograft (7 patients) or autografts (4 patients), the other 3 patients underwent below-knee amputation. Three patients with osteosarcoma of distal fibula reconstructed with ipsilateral fibular head, 3 patients with calcaneus osteosarcoma underwent total calcanectomy and reconstructed with fibular segment and iliac crest. The mean follow-up was 36.4 months.RESULTS:Five of 7 (71.4%) patients with allograft reconstruction were associated with delayed wound healing, however, only 1 of 10 patients with autograft had this problem (P = 0.036). One local recurrence was observed, 2 osteosarcoma patients died of disseminated disease. The estimated 2-year and 5-year overall survival for the patients with malignant tibial sarcomas were 92.9% and 79.6% respectively, for the patients with distal tibial high-grade osteosarcoma were 87.5% and 70.0% respectively. The mean functional MSTS score was 82% for limb salvage patients.CONCLUSIONS:The survival of patients with primary malignant bone tumor of distal lower extremity seems to be better than that of other sites. Limb salvage can provide satisfactory local control and functional results.

[Micronutritional supplementation in the ARMD].

Soft Tissue Tumors Of The Lower Leg, Foot And Ankle: A Cross-Sectional Observational Study Analysing 376 Cases

Symptoms and Signs Associated with Benign and Malignant Proximal Fibular Tumors: a Clinicopathological Analysis of 52 Cases.

Tumours of the foot: A 10 years retrospective analysis

Operative and Nonoperative Risks in the Cardiac Patient †

Benefits Associated With Early Diagnosis and Treatment of Soft Tissue Sarcomas of the Foot and Ankle

Update on the Perspective of a University Tumour Institute

Enhanced accuracy and reduced delay in diagnosing bone tumors within an expert sarcoma network: A nationwide study

Malignant Fibrous Neoplasms of Long Bones: Analysis of the Surveillance, Epidemiology, and End Results Database from 1973 to 2015

Clinicopathological Profile and Survival Outcomes in Patients with Localised Extremity Synovial Sarcomas

Clinical features and surgical management of metastatic skeletal diseases distal to the elbow and knee

[Experimental phaco-emulsification in the rabbit. Induced corneal endothelial lesions, regeneration at 24 hours (author's transl)].

Osteosarcomas of the hand and foot: A sarcoma‐center case series experience

Lateral malleolus en bloc resection for the distal fibula osteosarcoma based on a new classification and proposed reconstruction choice: analysis of 6 cases prognosis and literature review

The clinical significance of indeterminate pulmonary nodules in patients with primary bone sarcoma: a systematic review

P059 Cutaneous sarcomas: a 5-year review of treatment outcomes and literature

Osteolytic lesions of the calcaneus: results from a multicentre study

Surgical Treatment of Proximal Fibula Osteosarcoma: a Report of 18 Cases

Synovial Sarcoma in the Plantar Region: A Case Report and Literature Review

Contemporary surgical management of osteosarcoma and Ewing sarcoma

[The Survival and Functional Outcome of Primary Bone Sarcomas in Distal Lower Extremity].